Vor Biopharma

VOR · NASDAQ

$19.03+$0.99 (+5.49%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $18.04

Latest news

Press releaseSep 29, 8:05 AM ETGlobe Newswire
Telitacicept Demonstrates Deep and Durable Minimal Symptom Expression Through 48 Weeks in Generalized Myasthenia Gravis
Press releaseSep 8, 7:00 AM ETGlobe Newswire
Vor Completes Enrollment of Global Phase 3 UPSTREAM MG Trial and Expands Telitacicept Global Franchise into Ocular Myasthenia Gravis
Press releaseAug 11, 9:30 AM ETGlobe Newswire
Vor Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Press releaseJul 7, 4:01 PM ETGlobe Newswire
Vor Bio Appoints David Zaccardelli to Board of Directors
NewsJun 8, 8:33 AM ET
Vor Bio Announces Conditional China National Medicinal Products Administration Approval Of Telitacicept For The Treatment Of Adult Patients With IgAN
Press releaseJun 8, 8:31 AM ETGlobe Newswire
Telitacicept Receives NMPA Approval for the Treatment of Sjögren's Disease in China
Press releaseJun 8, 8:30 AM ETGlobe Newswire
Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China
Press releaseMay 14, 8:30 AM ETGlobe Newswire
Vor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicine
Press releaseMay 13, 8:30 AM ETGlobe Newswire
Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
Press releaseMar 30, 8:01 AM ETGlobe Newswire
Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
NewsMar 27, 10:29 AM ETAvi Kapoor
Oxford Industries Posts Q4 Results, Joins ADMA Biologics, Vor Biopharma And Other Big Stocks Moving Higher On Friday
NewsDec 22, 4:05 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsDec 9, 12:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsDec 9, 7:21 AM ET
Market-Moving News for December 9th
NewsNov 11, 12:17 PM ETAvi Kapoor
Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump
NewsNov 11, 12:09 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsNov 11, 9:43 AM ETVandana Singh
Vor Biopharma Secures $100 Million Offering After Reporting Efficacy In Kidney Disease Trial
NewsNov 11, 9:40 AM ETAvi Kapoor
US Stocks Mixed; Sea Shares Gain After Q3 Results
NewsNov 11, 7:07 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsNov 11, 5:55 AM ETAvi Kapoor
Why Rocket Lab Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
NewsNov 10, 4:07 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsOct 16, 10:50 AM ETVandana Singh
Novartis Strengthens Kidney Disease Pipeline With Promising Data
NewsOct 14, 12:22 PM ETVandana Singh
Vor Bio's Collaborator Delivers Positive Results For Telitacicept In Autoimmune Disorder That Impacts Tears
Press releaseSep 17, 9:00 PM ETPRNewswire
Results of China Phase III Clinical Study of Telitacicept for Generalized Myasthenia Gravis Selected for Oral Presentation at 2025 AANEM Annual Meeting
NewsAug 28, 12:40 PM ETVandana Singh
FDA Eases Monitoring Burden For Kidney Disease Patients On Travere Therapeutics' Filspari
Press releaseAug 28, 2:00 AM ETBusiness Wire
PureTech Health plc – Half-Year Report
NewsAug 27, 1:21 PM ETVandana Singh
Vor Bio's Investigational Drug Scores Phase 3 Win In Autoimmune Kidney Disease Trial
NewsAug 13, 11:15 AM ETVandana Singh
Vor Bio Rallies On Strong Data For Autoimmune Drug Candidate
NewsJul 3, 1:07 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsJun 30, 2:31 PM ETVandana Singh
Vor Biopharma's RemeGen Deal Paves Way For Multi-Billion Dollar Autoimmune Market
NewsJun 26, 5:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsJun 26, 1:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsJun 26, 12:12 PM ETNabaparna Bhattacharya
Why This Biotech Stock Just Doubled In A Single Day
NewsJun 26, 9:53 AM ETAvi Kapoor
Dow Surges 200 Points; US GDP Contracts 0.5%
NewsJun 26, 8:08 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseJun 26, 2:00 AM ETBusiness Wire
PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement
NewsMay 8, 1:06 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsMay 8, 12:46 PM ETAvi Kapoor
Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings
NewsMay 8, 9:50 AM ETAvi Kapoor
Dow Jumps Over 200 Points; US Initial Jobless Claims Fall
Press releaseApr 30, 2:00 AM ETBusiness Wire
PureTech Announces Annual Results for Year Ended December 31, 2024
NewsSep 10, 6:41 AM ETAvi Kapoor
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Press releaseSep 6, 2:00 AM ETBusiness Wire
PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Telitacicept Demonstrates Deep and Durable Minimal Symptom Expression Through 48 Weeks in Generalized Myasthenia Gravis

Vor Completes Enrollment of Global Phase 3 UPSTREAM MG Trial and Expands Telitacicept Global Franchise into Ocular Myasthenia Gravis

Vor Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Vor Bio Appoints David Zaccardelli to Board of Directors

Vor Bio Announces Conditional China National Medicinal Products Administration Approval Of Telitacicept For The Treatment Of Adult Patients With IgAN

Telitacicept Receives NMPA Approval for the Treatment of Sjögren's Disease in China

Telitacicept Receives NMPA Conditional Approval for the Treatment of IgA Nephropathy in China

Vor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicine

Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update

Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Oxford Industries Posts Q4 Results, Joins ADMA Biologics, Vor Biopharma And Other Big Stocks Moving Higher On Friday

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

Market-Moving News for December 9th

Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump

12 Health Care Stocks Moving In Tuesday's Intraday Session

Vor Biopharma Secures $100 Million Offering After Reporting Efficacy In Kidney Disease Trial

US Stocks Mixed; Sea Shares Gain After Q3 Results

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why Rocket Lab Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Monday's After-Market Session

Novartis Strengthens Kidney Disease Pipeline With Promising Data

Vor Bio's Collaborator Delivers Positive Results For Telitacicept In Autoimmune Disorder That Impacts Tears

Results of China Phase III Clinical Study of Telitacicept for Generalized Myasthenia Gravis Selected for Oral Presentation at 2025 AANEM Annual Meeting

FDA Eases Monitoring Burden For Kidney Disease Patients On Travere Therapeutics' Filspari

PureTech Health plc – Half-Year Report

Vor Bio's Investigational Drug Scores Phase 3 Win In Autoimmune Kidney Disease Trial

Vor Bio Rallies On Strong Data For Autoimmune Drug Candidate

12 Health Care Stocks Moving In Thursday's Intraday Session

Vor Biopharma's RemeGen Deal Paves Way For Multi-Billion Dollar Autoimmune Market

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Thursday's Intraday Session

Why This Biotech Stock Just Doubled In A Single Day

Dow Surges 200 Points; US GDP Contracts 0.5%

12 Health Care Stocks Moving In Thursday's Pre-Market Session

PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement

12 Health Care Stocks Moving In Thursday's Intraday Session

Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings

Dow Jumps Over 200 Points; US Initial Jobless Claims Fall

PureTech Announces Annual Results for Year Ended December 31, 2024

Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies